Rockefeller Capital Management »

Avita Therapeutics shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $759 220 3.45

More positions owned by Rockefeller Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Blackrock (BLK)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Visa Com Cl A (V)
NVIDIA Corporation (NVDA)
Costco Wholesale Corporation (COST)
Thermo Fisher Scientific (TMO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
salesforce (CRM)

View all positions for Rockefeller Capital Management

Top funds holding Avita Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
State Street Corporation
Northern Trust
Millennium Management
AQR Capital Management
Bridgeway Capital Management
Divisadero Street Capital Management
UBS Group
Goldman Sachs Group
Citadel Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Charles Schwab Investment Management
Nuveen

View all funds holding Avita Therapeutics